title: Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.
abstract: In recent years, various nanotechnology platforms in the area of medical biology, including both diagnostics and therapy, have gained remarkable attention. Moreover, research and development of engineered multifunctional nanoparticles as pharmaceutical drug carriers have spurred exponential growth in applications to medicine in the last decade. Design principles of these nanoparticles, including nanoemulsions, dendrimers, nano-gold, liposomes, drug-carrier conjugates, antibody-drug complexes, and magnetic nanoparticles, are primarily based on unique assemblies of synthetic, natural, or biological components, including but not limited to synthetic polymers, metal ions, oils, and lipids as their building blocks. However, the potential success of these particles in the clinic relies on consideration of important parameters such as nanoparticle fabrication strategies, their physical properties, drug loading efficiencies, drug release potential, and, most importantly, minimum toxicity of the carrier itself. Among these, lipid-based nanoparticles bear the advantage of being the least toxic for in vivo applications, and significant progress has been made in the area of DNA/RNA and drug delivery using lipid-based nanoassemblies. In this review, we will primarily focus on the recent advances and updates on lipid-based nanoparticles for their projected applications in drug delivery. We begin with a review of current activities in the field of liposomes (the so-called honorary nanoparticles), and challenging issues of targeting and triggering will be discussed in detail. We will further describe nanoparticles derived from a novel class of amphipathic lipids called bolaamphiphiles with unique lipid assembly features that have been recently examined as drug/DNA delivery vehicles. Finally, an overview of an emerging novel class of particles (based on lipid components other than phospholipids), solid lipid nanoparticles and nanostructured lipid carriers will be presented. We conclude with a few examples of clinically successful formulations of currently available lipid-based nanoparticles.
authors.affiliation: Center for Cancer Research Nanobiology Program, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702-1201, USA. apuri@helix.nih.gov
authors.forename: Anu
authors.initials: A
authors.lastname: Puri
authors.forename: Kristin
authors.initials: K
authors.lastname: Loomis
authors.forename: Brandon
authors.initials: B
authors.lastname: Smith
authors.forename: Jae-Ho
authors.initials: JH
authors.lastname: Lee
authors.forename: Amichai
authors.initials: A
authors.lastname: Yavlovich
authors.forename: Eliahu
authors.initials: E
authors.lastname: Heldman
authors.forename: Robert
authors.initials: R
authors.lastname: Blumenthal
mesh_terms: D000818:Animals; D004247:DNA / Q000008:administration & dosage; D004337:Drug Carriers / Q000009:adverse effects / Q000737:chemistry; D016503:Drug Delivery Systems; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008055:Lipids / Q000009:adverse effects / Q000737:chemistry*; D008081:Liposomes; D053758:Nanoparticles; D036103:Nanotechnology; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*
chemical_list: D004337:Drug Carriers; D008055:Lipids; D008081:Liposomes; D004364:Pharmaceutical Preparations; D004247:DNA
references.citation: Cancer Res. 2003 Jan 1;63(1):86-92
references.pmid: 12517782
references.citation: Ann Oncol. 2007 Apr;18(4):716-21
references.pmid: 17301073
references.citation: Langmuir. 2005 Aug 16;21(17):7638-45
references.pmid: 16089364
references.citation: Cancer. 2009 Aug 1;115(15):3475-82
references.pmid: 19536896
references.citation: Mol Cancer Ther. 2002 Mar;1(5):337-46
references.pmid: 12489850
references.citation: J Pharm Sci. 2001 Jun;90(6):667-80
references.pmid: 11357170
references.citation: Leuk Lymphoma. 2005 Jun;46(6):795-802
references.pmid: 16019523
references.citation: Biochem Biophys Res Commun. 2004 Apr 30;317(2):515-21
references.pmid: 15063787
references.citation: Toxicol Pathol. 2008 Jan;36(1):21-9
references.pmid: 18337218
references.citation: Clin Pharmacokinet. 2003;42(5):419-36
references.pmid: 12739982
references.citation: J Org Chem. 2005 Apr 1;70(7):2606-15
references.pmid: 15787550
references.citation: Cancer Res. 1998 Aug 1;58(15):3320-30
references.pmid: 9699662
references.citation: Langmuir. 2008 Jun 1;24(13):6965-80
references.pmid: 18512883
references.citation: Drug Deliv. 2003 Oct-Dec;10(4):245-50
references.pmid: 14612340
references.citation: J Control Release. 2008 Feb 18;126(1):50-8
references.pmid: 18068849
references.citation: Pharm Res. 2004 Dec;21(12):2153-7
references.pmid: 15648245
references.citation: Urol Oncol. 2008 Jan-Feb;26(1):74-85
references.pmid: 18190835
references.citation: J Liposome Res. 2008;18(2):145-57
references.pmid: 18569449
references.citation: J Biol Chem. 1993 Nov 25;268(33):24847-54
references.pmid: 8227046
references.citation: Crit Rev Ther Drug Carrier Syst. 1998;15(6):587-627
references.pmid: 9883391
references.citation: Int J Pharm. 2008 Jun 5;357(1-2):272-9
references.pmid: 18329201
references.citation: J Mol Biol. 1965 Aug;13(1):238-52
references.pmid: 5859039
references.citation: J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3215-21
references.pmid: 17048539
references.citation: PDA J Pharm Sci Technol. 2008 Sep-Oct;62(5):362-79
references.pmid: 19055232
references.citation: Drug Deliv. 2007 Feb;14(2):61-7
references.pmid: 17364869
references.citation: Mol Med Today. 1996 Jun;2(6):242-9
references.pmid: 8796897
references.citation: Biochemistry. 1996 Feb 27;35(8):2618-24
references.pmid: 8611565
references.citation: FEBS Lett. 1995 Nov 13;375(1-2):113-6
references.pmid: 7498457
references.citation: Chem Phys Lipids. 2008 Jun;153(2):85-97
references.pmid: 18316039
references.citation: FEBS Lett. 1983 Apr 18;154(2):373-7
references.pmid: 6832376
references.citation: Bioconjug Chem. 2009 Jul;20(7):1404-11
references.pmid: 19534457
references.citation: Curr Drug Deliv. 2005 Oct;2(4):369-81
references.pmid: 16305440
references.citation: Infect Immun. 2000 Jan;68(1):54-63
references.pmid: 10603368
references.citation: Nanomedicine (Lond). 2009 Feb;4(2):177-91
references.pmid: 19193184
references.citation: Bioorg Med Chem. 2005 Sep 1;13(17):5043-54
references.pmid: 15955702
references.citation: Pharm Res. 2002 Jun;19(6):875-80
references.pmid: 12134960
references.citation: Expert Opin Investig Drugs. 2009 Aug;18(8):1197-218
references.pmid: 19604121
references.citation: Curr Drug Deliv. 2005 Oct;2(4):353-62
references.pmid: 16305438
references.citation: Biomed Pharmacother. 2004 Apr;58(3):168-72
references.pmid: 15082339
references.citation: Clin Cancer Res. 2002 Apr;8(4):1172-81
references.pmid: 11948130
references.citation: J Med Chem. 2005 Nov 17;48(23):7305-14
references.pmid: 16279790
references.citation: Drugs. 1997;54 Suppl 4:15-21
references.pmid: 9361957
references.citation: J Control Release. 2005 Oct 3;107(2):262-75
references.pmid: 16125816
references.citation: Chem Phys Lipids. 1999 Jun;99(2):125-37
references.pmid: 10390836
references.citation: Eur J Pharm Biopharm. 2005 Aug;60(3):361-72
references.pmid: 15996577
references.citation: Bull Exp Biol Med. 2005 Dec;140(6):733-5
references.pmid: 16848239
references.citation: Int J Biol Macromol. 2008 Oct 1;43(3):320-4
references.pmid: 18619484
references.citation: Nat Rev Cancer. 2002 Oct;2(10):750-63
references.pmid: 12360278
references.citation: Expert Opin Pharmacother. 2002 Dec;3(12):1739-51
references.pmid: 12472371
references.citation: Colloids Surf B Biointerfaces. 2007 Nov 15;60(2):174-9
references.pmid: 17656075
references.citation: Biomaterials. 2008 Oct;29(30):4129-36
references.pmid: 18667234
references.citation: Biomaterials. 2009 Jan;30(2):226-32
references.pmid: 18851881
references.citation: Chem Commun (Camb). 2001 Dec 7;(23):2442-3
references.pmid: 12240005
references.citation: Biophys J. 2004 Apr;86(4):2615-29
references.pmid: 15041697
references.citation: J Drug Target. 2005 Apr;13(3):179-87
references.pmid: 16036306
references.citation: Ann N Y Acad Sci. 2003 Dec;1002:78-89
references.pmid: 14751825
references.citation: Expert Opin Drug Deliv. 2009 Jun;6(6):553-65
references.pmid: 19435406
references.citation: J Infect Dis. 2004 Mar 15;189(6):1024-34
references.pmid: 14999606
references.citation: Biochem Int. 1985 Mar;10(3):327-36
references.pmid: 2990474
references.citation: Acc Chem Res. 2008 Jan;41(1):120-9
references.pmid: 17655275
references.citation: Bioconjug Chem. 2009 Jun;20(6):1201-8
references.pmid: 19435362
references.citation: Nucleic Acids Res. 2004 Mar 16;32(5):e48
references.pmid: 15026537
references.citation: Nature. 1997 Jun 5;387(6633):580-3
references.pmid: 9177344
references.citation: J Liposome Res. 2008;18(4):293-307
references.pmid: 18937120
references.citation: Langmuir. 2004 Jul 6;20(14):5969-77
references.pmid: 16459618
references.citation: Curr Opin Chem Biol. 2009 Jun;13(3):256-62
references.pmid: 19419901
references.citation: Eur J Pharm Biopharm. 2005 Sep;61(1-2):77-86
references.pmid: 16011893
references.citation: Adv Drug Deliv Rev. 2004 Apr 29;56(8):1055-8
references.pmid: 15094205
references.citation: Science. 1989 Sep 22;245(4924):1371-4
references.pmid: 2781283
references.citation: Biochim Biophys Acta. 2008 Dec;1778(12):2749-56
references.pmid: 18762164
references.citation: Nat Rev Drug Discov. 2008 Sep;7(9):771-82
references.pmid: 18758474
references.citation: Eur J Pharm Biopharm. 2000 Jul;50(1):161-77
references.pmid: 10840199
references.citation: J Control Release. 2008 Apr 21;127(2):97-109
references.pmid: 18313785
references.citation: Biochem Biophys Res Commun. 1981 Jul 16;101(1):131-6
references.pmid: 7283995
references.citation: Methods Biochem Anal. 1988;33:337-462
references.pmid: 3282152
references.citation: Biophys J. 1976 Jan;16(1):13-26
references.pmid: 1244887
references.citation: Hum Gene Ther. 1999 Dec 10;10(18):2941-52
references.pmid: 10609655
references.citation: Eur J Pharm Sci. 2006 Feb;27(2-3):226-36
references.pmid: 16298113
references.citation: Biochim Biophys Acta. 1981 Nov 6;648(2):192-8
references.pmid: 7306536
references.citation: J Therm Anal Calorim. 2009 Oct 1;98(1):97-104
references.pmid: 20160877
references.citation: Adv Drug Deliv Rev. 2008 Jun 30;60(10):1193-208
references.pmid: 18474406
references.citation: Biochim Biophys Acta. 1995 Feb 15;1233(2):134-44
references.pmid: 7865538
references.citation: Biochim Biophys Acta. 2001 Oct 1;1514(2):303-17
references.pmid: 11557029
references.citation: Science. 1978 Dec 22;202(4374):1290-3
references.pmid: 364652
references.citation: Int J Pharm. 2000 Sep 15;205(1-2):15-21
references.pmid: 11000538
references.citation: Langmuir. 2007 Apr 10;23(8):4634-41
references.pmid: 17355159
references.citation: Retina. 2008 Jan;28(1):147-9
references.pmid: 18185152
references.citation: Langmuir. 2004 Sep 28;20(20):8839-45
references.pmid: 15379515
references.citation: Clin Pharmacol Ther. 2008 May;83(5):761-9
references.pmid: 17957183
references.citation: Chem Phys Lipids. 2009 Feb;157(2):94-103
references.pmid: 19094974
references.citation: Blood. 2002 Jul 15;100(2):594-602
references.pmid: 12091353
references.citation: J Phys Chem B. 2009 Jan 29;113(4):1143-52
references.pmid: 19123825
references.citation: Tuberculosis (Edinb). 2005 Jul;85(4):227-34
references.pmid: 15922668
references.citation: Clin Cancer Res. 2009 Mar 15;15(6):1973-80
references.pmid: 19276264
references.citation: Biochem Soc Trans. 2007 Feb;35(Pt 1):61-7
references.pmid: 17233602
references.citation: Br J Pharmacol. 2009 May;157(2):166-78
references.pmid: 19459843
references.citation: Biochim Biophys Acta. 1993 Sep 19;1151(2):201-15
references.pmid: 8373796
references.citation: Pharm Res. 2008 Oct;25(10):2262-71
references.pmid: 18516666
references.citation: Biophys J. 2007 Oct 15;93(8):2609-21
references.pmid: 17573422
references.citation: Toxicol Appl Pharmacol. 2009 Aug 1;238(3):280-8
references.pmid: 19379767
references.citation: Clin Infect Dis. 1999 Jan;28(1):42-8; discussion 49-51
references.pmid: 10028069
references.citation: Int J Pharm. 1999 Nov 10;190(1):49-56
references.pmid: 10528096
references.citation: Nanomedicine. 2005 Jun;1(2):101-9
references.pmid: 17292064
references.citation: Prog Lipid Res. 2003 Sep;42(5):439-62
references.pmid: 12814645
references.citation: Methods Mol Med. 2005;109:389-402
references.pmid: 15585933
references.citation: J Drug Target. 1999;7(2):101-12
references.pmid: 10617296
references.citation: Adv Drug Deliv Rev. 2007 Jul 10;59(6):478-90
references.pmid: 17543416
references.citation: Biochim Biophys Acta. 2001 Dec 1;1515(2):167-76
references.pmid: 11718672
references.citation: J Neurooncol. 2007 Jan;81(2):201-8
references.pmid: 16941075
references.citation: Expert Opin Biol Ther. 2008 Aug;8(8):1063-70
references.pmid: 18613759
references.citation: Biochemistry. 1997 Jan 7;36(1):66-75
references.pmid: 8993319
references.citation: Biochim Biophys Acta. 1994 Jan 3;1189(1):96-100
references.pmid: 8305465
references.citation: J Cell Biochem. 1985;28(1):23-9
references.pmid: 4030900
references.citation: Drug Deliv. 2007 Mar;14(3):171-5
references.pmid: 17454037
references.citation: Clin Cancer Res. 2008 Dec 15;14(24):8161-8
references.pmid: 19088031
references.citation: Drug Discov Today. 2001 Jan 1;6(1):44-51
references.pmid: 11165172
references.citation: Cancer Chemother Pharmacol. 2010 May;66(1):43-52
references.pmid: 19779718
references.citation: J Clin Oncol. 2001 Mar 1;19(5):1444-54
references.pmid: 11230490
references.citation: Biochem Soc Trans. 1975;3(5):613-8
references.pmid: 53164
references.citation: Langmuir. 2005 Aug 2;21(16):7476-82
references.pmid: 16042482
references.citation: Biochim Biophys Acta. 1986 Mar 27;856(1):36-40
references.pmid: 3955034
references.citation: Acta Clin Belg. 2002 Mar-Apr;57(2):53-7
references.pmid: 12152239
references.citation: Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11460-4
references.pmid: 1763060
references.citation: J Control Release. 2003 Sep 4;91(3):417-29
references.pmid: 12932719
references.citation: Antimicrob Agents Chemother. 1992 Sep;36(9):1978-80
references.pmid: 1416890
references.citation: Curr Opin Chem Biol. 2005 Aug;9(4):343-6
references.pmid: 15967706
references.citation: Int J Pharm. 2008 Sep 1;361(1-2):239-44
references.pmid: 18586075
references.citation: Nanomedicine (Lond). 2009 Jan;4(1):105-18
references.pmid: 19093899
references.citation: Soft Matter. 2008 Jul 16;4(8):1681-1687
references.pmid: 32907162
references.citation: Expert Opin Drug Deliv. 2008 Jan;5(1):25-44
references.pmid: 18095927
references.citation: Int J Pharm. 2000 Apr 20;199(2):167-77
references.pmid: 10802410
references.citation: J Pharm Pharmacol. 2007 Jul;59(7):935-40
references.pmid: 17637187
references.citation: Science. 2004 Mar 19;303(5665):1818-22
references.pmid: 15031496
references.citation: J Immunol. 1979 Feb;122(2):585-91
references.pmid: 368242
references.citation: Acc Chem Res. 2003 May;36(5):335-41
references.pmid: 12755643
references.citation: Chem Commun (Camb). 2006 Sep 14;(34):3622-4
references.pmid: 17047785
references.citation: Mol Cancer Ther. 2006 Apr;5(4):818-24
references.pmid: 16648551
references.citation: Curr Drug Deliv. 2005 Oct;2(4):363-8
references.pmid: 16305439
references.citation: Bone Marrow Transplant. 2000 Apr;25(8):879-84
references.pmid: 10808210
references.citation: Biomaterials. 2008 Jan;29(3):359-69
references.pmid: 17964645
references.citation: J Clin Oncol. 2004 Jul 1;22(13):2662-70
references.pmid: 15226333
references.citation: Int J Pharm. 2002 Aug 21;242(1-2):121-8
references.pmid: 12176234
references.citation: Eur J Pharm Biopharm. 2003 Jul;56(1):67-72
references.pmid: 12837483
references.citation: Adv Drug Deliv Rev. 2001 Dec 31;53(3):285-305
references.pmid: 11744173
references.citation: Int J Nanomedicine. 2007;2(4):595-607
references.pmid: 18203427
references.citation: Int J Nanomedicine. 2007;2(3):289-300
references.pmid: 18019829
references.citation: Chem Rev. 2004 Jun;104(6):2901-37
references.pmid: 15186184
references.citation: Adv Drug Deliv Rev. 2004 Apr 29;56(8):1177-92
references.pmid: 15094214
references.citation: J Biotechnol. 2007 May 31;130(1):85-94
references.pmid: 17442442
references.citation: Biomaterials. 2009 Oct;30(30):6055-64
references.pmid: 19665223
references.citation: Hum Gene Ther. 2006 Jan;17(1):117-24
references.pmid: 16409130
references.citation: Cell Mol Biol Lett. 2002;7(3):889-94
references.pmid: 12378272
references.citation: Curr Top Med Chem. 2008;8(14):1165-79
references.pmid: 18855703
references.citation: Langmuir. 2006 Feb 28;22(5):2045-9
references.pmid: 16489787
references.citation: J Control Release. 2001 Jul 6;74(1-3):129-34
references.pmid: 11489489
references.citation: Biochim Biophys Acta. 2007 Jul;1768(7):1796-804
references.pmid: 17531950
references.citation: Pharm Res. 2007 Dec;24(12):2402-11
references.pmid: 17828616
references.citation: Biochem Biophys Res Commun. 1999 Aug 27;262(2):406-10
references.pmid: 10462488
references.citation: Adv Drug Deliv Rev. 2004 May 7;56(9):1257-72
references.pmid: 15109768
references.citation: Eur J Pharm Biopharm. 2009 Feb;71(2):161-72
references.pmid: 18824097
references.citation: Leuk Lymphoma. 2008 May;49(5):924-31
references.pmid: 18464112
references.citation: Int J Hyperthermia. 2006 May;22(3):205-13
references.pmid: 16754340
references.citation: Drugs. 1997;54 Suppl 4:8-14
references.pmid: 9361956
references.citation: ChemMedChem. 2008 Dec;3(12):1839-43
references.pmid: 19012296
references.citation: Nat Mater. 2009 Apr;8(4):331-6
references.pmid: 19234444
references.citation: Lung Cancer. 2010 May;68(2):240-7
references.pmid: 19628292
references.citation: Hum Gene Ther. 2002 Feb 10;13(3):469-81
references.pmid: 11860713
references.citation: Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S81-91
references.pmid: 11033430
references.citation: Cancer Res. 2006 Jul 1;66(13):6732-40
references.pmid: 16818648
references.citation: Bioconjug Chem. 1999 Mar-Apr;10(2):289-98
references.pmid: 10077479
references.citation: Biochim Biophys Acta. 1981 Feb 23;663(2):506-15
references.pmid: 7213783
references.citation: J Am Chem Soc. 2003 Oct 22;125(42):12680-1
references.pmid: 14558795
references.citation: Adv Drug Deliv Rev. 2007 Jul 10;59(6):522-30
references.pmid: 17602783
references.citation: J Control Release. 2010 Feb 25;142(1):108-21
references.pmid: 19819275
references.citation: J Liposome Res. 2010 Jun;20(2):147-59
references.pmid: 19848552
references.citation: Chem Rev. 2003 Jan;103(1):53-69
references.pmid: 12517181
references.citation: J Colloid Interface Sci. 2005 May 15;285(2):590-8
references.pmid: 15837476
references.citation: Int J Cancer. 1999 Mar 1;80(5):723-30
references.pmid: 10048974
references.citation: Org Biomol Chem. 2006 May 7;4(9):1730-40
references.pmid: 16633565
references.citation: Cancer Res. 2005 Dec 15;65(24):11631-8
references.pmid: 16357174
references.citation: Adv Drug Deliv Rev. 2001 Dec 31;53(3):273-84
references.pmid: 11744172
references.citation: Biophys Chem. 2009 Feb;139(2-3):75-83
references.pmid: 19010585
references.citation: J Control Release. 2009 Jan 19;133(2):132-8
references.pmid: 18929605
references.citation: Mol Pharm. 2009 Jul-Aug;6(4):1041-51
references.pmid: 19366234
references.citation: Cancer Res. 2000 Mar 1;60(5):1197-201
references.pmid: 10728674
references.citation: Angew Chem Int Ed Engl. 2009;48(5):872-97
references.pmid: 19142939
references.citation: J Biomech Eng. 2009 Jul;131(7):074005
references.pmid: 19655996
references.citation: Biochim Biophys Acta. 1994 Aug 3;1193(2):247-54
references.pmid: 8054346
references.citation: Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):444-8
references.pmid: 1988944
references.citation: Ann Oncol. 2004 Apr;15(4):665-70
references.pmid: 15033677
references.citation: J Control Release. 2008 Mar 20;126(3):187-204
references.pmid: 18261822
references.citation: Cancer. 2006 Jan 1;106(1):120-7
references.pmid: 16331634
references.citation: Clin Cancer Res. 2003 Dec 15;9(17):6551-9
references.pmid: 14695160
references.citation: Invest New Drugs. 2004 Aug;22(3):263-75
references.pmid: 15122073
references.citation: Pharm Res. 2009 Mar;26(3):529-38
references.pmid: 19015959
references.citation: Chem Phys Lipids. 1988 Nov;49(1-2):39-47
references.pmid: 3233710
references.citation: Curr Drug Deliv. 2009 Jul;6(3):217-26
references.pmid: 19604135
references.citation: Biophys J. 2002 Apr;82(4):2101-10
references.pmid: 11916866
references.citation: Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):165-96
references.pmid: 11311991
references.citation: Recent Pat Drug Deliv Formul. 2008;2(2):120-35
references.pmid: 19075903
references.citation: Chem Commun (Camb). 2005 Jun 28;(24):3021-3
references.pmid: 15959571
references.citation: Clin Cancer Res. 2005 May 1;11(9):3465-74
references.pmid: 15867249
references.citation: Annu Rev Biomed Eng. 2000;2:339-76
references.pmid: 11701516
references.citation: J Antimicrob Chemother. 1991 Oct;28 Suppl B:83-91
references.pmid: 1778895
references.citation: Int J Pharm. 2007 Aug 1;340(1-2):198-206
references.pmid: 17482778
references.citation: Pharm Dev Technol. 2006;11(2):153-7
references.pmid: 16749525
references.citation: Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):139-48
references.pmid: 11311989
references.citation: Crit Rev Biotechnol. 1999;19(4):317-57
references.pmid: 10723627
references.citation: J Liposome Res. 2008;18(1):21-9
references.pmid: 18348069
references.citation: Curr Drug Deliv. 2004 Jul;1(3):299-312
references.pmid: 16305392
references.citation: Anticancer Drugs. 2007 Nov;18(10):1189-200
references.pmid: 17893520
references.citation: Pharm Res. 2005 Nov;22(11):1906-17
references.pmid: 16088429
references.citation: Biotechnol Prog. 2005 Jan-Feb;21(1):205-20
references.pmid: 15903260
references.citation: Mol Pharm. 2009 Sep-Oct;6(5):1264-76
references.pmid: 19432455
references.citation: J Pharm Pharmacol. 2009 Aug;61(8):1013-9
references.pmid: 19703344
references.citation: Biochem Biophys Res Commun. 2000 Sep 16;276(1):169-73
references.pmid: 11006101
references.citation: Pharm Res. 2008 Jul;25(7):1521-30
references.pmid: 18172580
references.citation: Colloids Surf B Biointerfaces. 2007 May 15;57(1):75-80
references.pmid: 17303394
references.citation: Biochem Biophys Res Commun. 1994 Jul 29;202(2):673-9
references.pmid: 8048936
references.citation: Semin Oncol. 2004 Dec;31(6 Suppl 13):196-205
references.pmid: 15717745
references.citation: J Control Release. 2005 Nov 2;108(1):112-20
references.pmid: 16169111
references.citation: Expert Opin Drug Deliv. 2008 Sep;5(9):1003-25
references.pmid: 18754750
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9343-8
references.pmid: 18607000
references.citation: Adv Drug Deliv Rev. 2007 Jul 10;59(6):491-504
references.pmid: 17532091
references.citation: Pharmacol Res. 2000 Oct;42(4):337-43
references.pmid: 10987994
references.citation: Chem Phys Lipids. 2009 Nov;162(1-2):1-16
references.pmid: 19703435
references.citation: Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1196-205
references.pmid: 16763815
references.citation: Clin Cancer Res. 2005 May 1;11(9):3567-73
references.pmid: 15867261
references.citation: Pharm Res. 1997 Apr;14(4):458-62
references.pmid: 9144731
references.citation: Invest New Drugs. 2007 Apr;25(2):155-9
references.pmid: 16957835
references.citation: Int J Pharm. 2003 Mar 18;254(1):55-8
references.pmid: 12615409
references.citation: Biochim Biophys Acta. 2003 Oct 31;1617(1-2):10-21
references.pmid: 14637015
references.citation: J Control Release. 2003 Dec 12;93(3):271-82
references.pmid: 14644577
references.citation: J Drug Target. 2008 Aug;16(7):605-10
references.pmid: 18686132
references.citation: J Org Chem. 1997 Apr 4;62(7):1924-1933
references.pmid: 11671492
references.citation: Prog Lipid Res. 2005 Jan;44(1):68-97
references.pmid: 15748655
references.citation: Biophys J. 1976 Jan;16(1):1-11
references.pmid: 1244886
references.citation: Biochim Biophys Acta. 2007 Jan;1768(1):21-9
references.pmid: 17046711
references.citation: Gene Ther. 2004 Oct;11(19):1434-40
references.pmid: 15229629
references.citation: Eur J Pharm Biopharm. 2004 Nov;58(3):673-80
references.pmid: 15451544
references.citation: Chem Phys Lipids. 2005 Jun;135(2):117-29
references.pmid: 15921973
references.citation: Biol Pharm Bull. 2007 May;30(5):972-8
references.pmid: 17473445
references.citation: Eur J Pharm Biopharm. 2007 Mar;65(3):300-8
references.pmid: 17156986
references.citation: Prog Lipid Res. 1988;27(3):153-75
references.pmid: 3151021
references.citation: Clin Cancer Res. 2004 Feb 1;10(3):1100-11
references.pmid: 14871990
references.citation: Int J Cancer. 2001 Dec 1;94(5):717-26
references.pmid: 11745468
references.citation: Langmuir. 2004 Mar 16;20(6):2416-23
references.pmid: 15835704
references.citation: Pharm Res. 2007 Jan;24(1):1-16
references.pmid: 17109211
references.citation: Int J Pharm. 2006 May 11;314(1):83-9
references.pmid: 16563671
references.citation: Biomacromolecules. 2009 Feb 9;10(2):197-209
references.pmid: 19123775
references.citation: AIDS Patient Care STDS. 1996 Apr;10(2):135
references.pmid: 11361702
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):992-1000
references.pmid: 19057023
references.citation: J Med Chem. 2004 Mar 25;47(7):1694-703
references.pmid: 15027860
references.citation: Biotechnol Prog. 2005 Jan-Feb;21(1):221-32
references.pmid: 15903261
references.citation: Nat Rev Drug Discov. 2005 Feb;4(2):145-60
references.pmid: 15688077